Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Elisa Balletto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Adenoviridae Infections, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Adenovirus infection (ADVi) is an emergent complication in adult patients undergoing allogeneic hematopoietic stem cell transplantation (allo‐HSCT) and is associated with poor outcome. Available data on risk factors and optimal management of ADVi in adult allo‐HSCT recipients are limited, and recommendations on monitoring and pre‐emptive therapy are mainly based on pediatric data.
Methods
In this single‐center, retrospective study, we reported all cases of positive ADV‐DNA from adult patients undergoing allo‐HSCT in the period 2014–2019. The study aimed to describe the incidence of ADVi at day +180 post‐transplant. Secondly to describe timing, clinical presentation, risk factors, and outcome of ADVi and to analyze the application of a screening strategy in our cohort.
Results
In 445 allo‐HSCT recipients, the day +180 incidence was: 9% (39/445) for ADVi, 5% (24/445) for ADV viremia (ADVv), and 3% (15/445) for localized ADVi. The median time to ADVi was 65 (IQR 19; 94) days after HSCT. ADVv‐related mortality was 13% (3/24), all cases occurring with blood max‐ADV‐DNA > 10^3 cp/mL. Independent risk factors for ADVi were diagnosis of lymphoproliferative disease ( p = .011) and acute graft‐versus‐host‐disease ( p = .021).
Conclusions
In our cohort, ADVi and ADVv were more frequent than previously reported. ADVv with max‐ADV‐DNA > 10^3 cp/mL was associated with ADV‐related mortality, thus careful monitoring and early initiation of treatment are advisable. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
- Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy.
- Division of Trapianto di cellule staminali e terapie cellulari, San Martino Hospital, Genoa, Italy.
- Hygiene Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
ORCID-Profile: Elisa Balletto
Zitieren
APA
Balletto, E., Ponzano, M., Raiola, A. M., Gambella, M., Grazia, C. D., Dominietto, A., Giannoni, L., Ghiso, A., Nicolini, L. A., Sepulcri, C., Ullah, N., Bruzzone, B., Signori, A., Angelucci, E., Bassetti, M., & Mikulska, M. (2024). Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome. Transplant Infectious Disease. https://doi.org/10.1111/tid.14215
Vancouver
Balletto E, Ponzano M, Raiola AM, Gambella M, Grazia CD, Dominietto A, et al. Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome. Transplant Infectious Disease. 2024. doi:10.1111/tid.14215
BibTeX
@article{Balletto2024,
author = {Balletto, Elisa and Ponzano, Marta and Raiola, Anna Maria and Gambella, Massimiliano and Grazia, Carmen Di and Dominietto, Alida and Giannoni, Livia and Ghiso, Anna and Nicolini, Laura Ambra and Sepulcri, Chiara and Ullah, Nadir and Bruzzone, Bianca and Signori, Alessio and Angelucci, Emanuele and Bassetti, Matteo and Mikulska, Malgorzata},
title = {Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14215}
}
EUVIMED